A PYMNTS Company

Ireland/US: High Court agrees to reverse pharma merger

By  |  January 27, 2015

Minnesota-based Medtronic’s purchase of an Irish healthcare company is almost finished.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The Irish High Court agreed to the acquisition of Covidien Monday morning.

    The deal puts both companies under a corporate parent based in Ireland, where corporations face taxes about one-third the U.S. rate.

    Medtronic, which will keep its executive offices in Minneapolis, will become a global maker of health-care goods with $27 billion in revenue and a combined 85,000 employees.

    Full Content: Kare 11

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.